Compounds > 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline
Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Acute Biphenotypic Leukemia

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Acute Biphenotypic Leukemia in 1 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uckun, FM1
Dibirdik, I1
Qazi, S1
Yiv, S1

Other Studies

1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Acute Biphenotypic Leukemia

ArticleYear
Therapeutic nanoparticle constructs of a JAK3 tyrosine kinase inhibitor against human B-lineage ALL cells.
    Arzneimittel-Forschung, 2010, Volume: 60, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Calibration; Cell Lineage; Chemistry, Pharmaceutical; Chr

2010